ハイスループットスクリーニングの世界市場予測（～ 2021）：細胞アッセイ、ラボオンチップ、バイオインフォマティクス、ウルトラハイスループットスクリーニング、ラベルフリー技術...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 36)
4.1 High-Throughput Screening: Market Overview
4.2 Asia-Pacific: High-Throughput Screening Services Market, By Type
4.3 Market: Geographic Snapshot
4.4 Market Size, By Application
4.5 Market: Geographic Mix

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
5.2.1.2 Rising Government Funding
5.2.1.3 Increasing R&D Spending
5.2.1.4 Technological Advancements
5.2.2 Market Restraints
5.2.2.1 Capital-Intensive Nature of HTS
5.2.2.2 Complexities in the Field of Assay Development
5.2.3 Market Opportunities
5.2.3.1 High Growth Opportunities in Emerging Markets
5.2.3.2 Growing Research Activities in Toxicology and Stem Cells

6 Industry Insights (Page No. – 47)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Suppliers
6.2.4 Bargaining Power of Buyers
6.2.5 Competitive Rivalry
6.3 Technological Trends
6.3.1 Label-Free Technology, an Emerging Trend
6.3.2 Automation & Miniaturization of HTS Techniques
6.4 HTS in Drug Discovery Process

7 High-Throughput Screening Market, By Product & Service (Page No. – 51)
7.1 Introduction
7.2 Consumables & Reagents
7.3 Instruments
7.4 Software & Services

8 High-Throughput Screening Market, By Technology (Page No. – 57)
8.1 Introduction
8.2 Cell-Based Assays
8.2.1 2d Cell Culture
8.2.2 3D Cell Culture
8.2.2.1 Scaffold-Based Technology
8.2.2.1.1 Hydrogels
8.2.2.1.1.1 Animal-Derived Hydrogels
8.2.2.1.1.2 Alginate/Agarose
8.2.2.1.1.3 Synthetic Hydrogels
8.2.2.1.2 Inert Matrix/Solid Scaffolds
8.2.2.2 Scaffold-Free Technology
8.2.2.2.1 Microplates
8.2.2.2.2 Hanging-Drop Plates
8.2.2.2.3 Ultra-Low Binding Plates
8.2.2.2.4 Other Scaffold-Free Technologies
8.2.3 Perfusion Cell Culture
8.3 Lab-On-A-Chip
8.4 Ultra-High-Throughput Screening
8.5 Label-Free Technology
8.6 Bioinformatics

9 High-Throughput Screening Market, By Application (Page No. – 85)
9.1 Introduction
9.2 Target Identification
9.3 Primary Screening
9.4 Toxicology Assessment
9.5 Other Applications

10 High-Throughput Screening Market, By End User (Page No. – 92)
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.3 Academic and Government Research Institutes
10.4 Contract Research Organizations
10.5 Other End Users

11 High-Throughput Screening Market, By Region (Page No. – 99)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 197)
12.1 Introduction
12.2 Strategic Overview
12.3 Market Share Analysis
12.4 Competitive Situation and Trends
12.4.1 Product Launches and Upgrades
12.4.2 Agreements, Collaborations, and Partnerships
12.4.3 Expansions
12.4.4 Acquisitions
12.4.5 Other Developments

13 Company Profiles (Page No. – 206)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 Agilent Technologies, Inc.
13.3 Danaher Corporation
13.4 Perkinelmer, Inc.
13.5 Thermo Fisher Scientific Inc.
13.6 Axxam S.P.A.
13.7 Tecan Group Ltd.
13.8 Bio-Rad Laboratories, Inc.
13.9 Hamilton Company
13.10 Sigma-Aldrich Corporation (A Division of Merck Millipore)
13.11 Aurora Biomed, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 236)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details